Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation symbols : Sny save search
Biond Biologics Announces Presentation of BND-35, a Novel Anti-ILT3 Antibody for Remodeling the Tumor Microenvironment, at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.93%
H: 0.0%
C: 0.0%
bnd-35 antibody association presentation cancer tumor research meeting
IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023
Published: 2023-12-11 (Crawled : 20:00) - prnewswire.com
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
fucaso presentation
Free Registration Is Now Open For Tribe Public’s CEO and Q&A Presentation Webinar Event “Accelerating Biotech Value Creation” Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023
Published: 2023-10-27 (Crawled : 13:00) - invobioscience.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
ceo free biotech presentation
Entera Bio Announces Formation of Clinical and Scientific Advisory Board and Poster Presentation at ASBMR 2022 Annual Meeting
Published: 2022-07-26 (Crawled : 12:20) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
ENTX | $2.51 -15.77% -18.73% 680K
|
Health Technology
|
| O: 4.55%
H: 2.72%
C: 2.17%
AMGN | $265.505 -0.66% -0.67% 1.7M
|
Health Technology
|
| O: 0.37%
H: 1.66%
C: 0.6%
meeting presentation
Biond Biologics Announces Oral Presentation for BND-67, an Inhibitor of CD28 Shedding, a Potential Novel Resistance Mechanism to Anti PD-1 Therapy, at the American Association for Cancer Research (AACR) 2022 Annual Meeting
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 4.78%
H: 0.0%
C: -5.78%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
bnd-67 america research presentation potential therapy cancer ism
Escient Pharmaceuticals Announces Data Presentations Highlighting the Preclinical and Clinical Development of EP547 at AASLD The Liver Meeting® Digital Experience 2021
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
presentation liver preclinical pre-clinical
Hope Alights at ECTIRMS 2021 as Companies Present New Data
Published: 2021-10-15 (Crawled : 16:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.35%
H: 1.12%
C: 0.89%
presentation
IDWeek Presentations Highlight Continued Response to COVID-19
Published: 2021-09-29 (Crawled : 18:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.33%
H: 5.54%
C: -0.81%
covid presentation response covid-19
Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting
Published: 2021-09-29 (Crawled : 13:15) - globenewswire.com
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
DNLI | $17.85 -2.25% -2.3% 990K
|
Health Technology
|
| O: 0.22%
H: 0.73%
C: -2.43%
presentation sclerosis
AstraZeneca COVID-19 and RSV presentations at IDWeek 2021 will showcase scientific progress in infectious diseases
Published: 2021-09-27 (Crawled : 12:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.15%
H: 0.01%
C: -0.37%
covid presentation disease infectious disease covid-19
Monalizumab Data from COAST Trial Presented at ESMO Congress 2021
Published: 2021-09-17 (Crawled : 12:00) - globenewswire.com
NVO | $123.9 -0.49% 0.23% 2.9M
|
Health Technology
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 32.17%
H: 57.24%
C: 6.58%
trial presentation
New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant Lymphoma
Published: 2021-06-09 (Crawled : 11:00) - globenewswire.com
NVO | $123.9 -0.49% 0.23% 2.9M
|
Health Technology
|
| O: 1.01%
H: 0.57%
C: 0.46%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 0.52%
H: 2.47%
C: -0.26%
presentation trial conference
New Lacutamab Data From Tellomak Trial to be Showcased in Oral Presentation at Upcoming 16th International Conference on Malignant LymphomaFirst clinical data of mycosis fungoides presented from the TELLOMAK trial
Published: 2021-06-09 (Crawled : 11:00) - biospace.com/
NVO | $123.9 -0.49% 0.23% 2.9M
|
Health Technology
|
| O: 1.01%
H: 0.57%
C: 0.46%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 0.52%
H: 2.47%
C: -0.26%
presentation trial conference
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.